Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/30/2000 | WO2000071737A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
11/30/2000 | WO2000071736A1 Isoflavonoid methylation enzyme |
11/30/2000 | WO2000071735A1 Composition of plant antimicrobial proteins |
11/30/2000 | WO2000071734A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
11/30/2000 | WO2000071733A1 Improved method for agrobacterium mediated transformation of cotton |
11/30/2000 | WO2000071732A2 Nucleotide sequence for increasing the defense reaction of a plant against infection by a pathogen |
11/30/2000 | WO2000071731A1 Phage-dependent super-production of biologically active protein and peptides |
11/30/2000 | WO2000071730A1 Method for inserting a nucleic acid fragment in a vector, uses thereof and kits therefor |
11/30/2000 | WO2000071729A2 Recombinant hosts suitable for simultaneous saccharification and fermentation |
11/30/2000 | WO2000071728A1 Recombinant bacterial phytases and uses thereof |
11/30/2000 | WO2000071727A1 Novel gene regulating the synthesis of abscisic acid |
11/30/2000 | WO2000071726A1 Methods to inhibit infectious agent transmission during xenotransplantation |
11/30/2000 | WO2000071725A2 Combination neisserial compositions |
11/30/2000 | WO2000071724A2 Novel compounds from moraxella catarrhalis |
11/30/2000 | WO2000071723A2 Methods for regulating protein conformation using molecular chaperones |
11/30/2000 | WO2000071722A1 Novel genes to control flowering, transgenic plants, and uses thereof |
11/30/2000 | WO2000071721A1 Novel gene regulating ethylene synthesis |
11/30/2000 | WO2000071720A1 Il-1 eta dna and polypeptides |
11/30/2000 | WO2000071719A1 Interleukin-1 hy2 materials and methods |
11/30/2000 | WO2000071718A1 Gene therapy of pulmonary disease |
11/30/2000 | WO2000071717A1 Secreted alpha-helical protein - 32 |
11/30/2000 | WO2000071716A2 Vascular endothelial growth factor dimers |
11/30/2000 | WO2000071715A1 Fibroblast growth factor 11 |
11/30/2000 | WO2000071714A2 Methods of reducing factor viii clearance and compositions therefor |
11/30/2000 | WO2000071713A1 Vascular endothelial growth factor variants |
11/30/2000 | WO2000071712A1 Dsif dominant negative variant |
11/30/2000 | WO2000071711A2 Differentially expressed genes in prostate cancer |
11/30/2000 | WO2000071710A2 Expression products of genes involved in diseases related to cholesterol metabolism |
11/30/2000 | WO2000071709A1 Polypeptides, vesicular carriers of glutamate and gaba |
11/30/2000 | WO2000071708A2 Use of ef-ts for treating smooth muscle cell hyperplasia |
11/30/2000 | WO2000071707A1 A method for the diagnosis and treatment of cancer and agents useful therefor |
11/30/2000 | WO2000071706A1 ANTISENSE TO c-myc FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE |
11/30/2000 | WO2000071705A1 Novel psychrotrophic bacterium and dna probe for detecting the bacterium |
11/30/2000 | WO2000071704A1 Promoter having specific activity to pistil tissue |
11/30/2000 | WO2000071703A2 Inhibition of histone deacetylase |
11/30/2000 | WO2000071702A1 Interaction-activated proteins |
11/30/2000 | WO2000071701A1 Method for generating split, non-transferable genes that are able to express an active protein product |
11/30/2000 | WO2000071700A1 Methods for separating, fractionating and analyzing gene of virus existing in water |
11/30/2000 | WO2000071699A1 Gene disruption method by using tobacco retrotransposon |
11/30/2000 | WO2000071698A2 Mixture for neutralizing enzyme inhibitors |
11/30/2000 | WO2000071696A1 Gene for regulating disease resistance in plants |
11/30/2000 | WO2000071695A1 Novel phytochelatin synthases and uses therefor |
11/30/2000 | WO2000071694A1 METHODS FOR DISPLAY OF HETERODIMERIC PROTEINS ON FILAMENTOUS PHAGE USING pVII and pIX, COMPOSITIONS, VECTORS AND COMBINATORIAL LIBRARIES |
11/30/2000 | WO2000071693A2 Method for selecting improved vectors |
11/30/2000 | WO2000071692A1 Refolding method of thrombin |
11/30/2000 | WO2000071686A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
11/30/2000 | WO2000071681A1 A polynucleotide motor, a motor system, their preparation and uses |
11/30/2000 | WO2000071679A2 Human oxidoreductase proteins |
11/30/2000 | WO2000071678A1 Inducible packaging cell lines for lentivirus vectors |
11/30/2000 | WO2000071670A2 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
11/30/2000 | WO2000071668A2 Method for identifying components involved in signal transduction pathways in higher plants |
11/30/2000 | WO2000071585A1 Human antibodies to staphylococcus aureus |
11/30/2000 | WO2000071584A1 Seven transmembrane receptor genes |
11/30/2000 | WO2000071583A1 Murine interleukin-1 homologue, il-1h3 |
11/30/2000 | WO2000071582A1 Fibroblast growth factor 14 |
11/30/2000 | WO2000071581A1 Novel polypeptide |
11/30/2000 | WO2000071579A2 Regulating organelle homeostasis in a cell factory |
11/30/2000 | WO2000071578A2 New polypeptides and their use for the rescue of fusion defective virus or retrovirus glycoproteins |
11/30/2000 | WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides |
11/30/2000 | WO2000071575A1 Models of prion disease |
11/30/2000 | WO2000071574A2 Antigenic neisserial peptides |
11/30/2000 | WO2000071573A2 Immunogenic peptides derived from mage and the use thereof |
11/30/2000 | WO2000071566A2 Novel organic anion transport proteins |
11/30/2000 | WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
11/30/2000 | WO2000071562A1 High specificity primers, amplification methods and kits |
11/30/2000 | WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
11/30/2000 | WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes |
11/30/2000 | WO2000071165A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
11/30/2000 | WO2000071164A1 Inhibition of gastric acid production and/or secretion |
11/30/2000 | WO2000071161A1 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferative drugs |
11/30/2000 | WO2000071158A1 Tagged epitope protein transposable element |
11/30/2000 | WO2000071155A2 New vaccine formulations - 2 |
11/30/2000 | WO2000071151A1 Liver function controlling agents |
11/30/2000 | WO2000071150A1 Tumor necrosis factor receptor 5 |
11/30/2000 | WO2000071141A1 Modified factor viii |
11/30/2000 | WO2000071096A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
11/30/2000 | WO2000071078A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
11/30/2000 | WO2000070944A1 Genetically defined animal models and genetic markers for estrogen-induced cancer |
11/30/2000 | WO2000050607A3 Goodpasture antigen binding protein |
11/30/2000 | WO2000050581A3 Isolation and characterization of a n. crassa silencing gene and uses thereof |
11/30/2000 | WO2000047750A3 Metalloproteases of the neprilysin family |
11/30/2000 | WO2000047739A3 Autoantigens for the diagnostic of endometriosis |
11/30/2000 | WO2000047738A3 Human and mouse trek-1 potassium channel protein and their use |
11/30/2000 | WO2000047735A3 NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha |
11/30/2000 | WO2000047615A3 Proteins related to neuronal regeneration and uses thereof |
11/30/2000 | WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
11/30/2000 | WO2000047610A3 Method for altering undesirable immune responses to polypeptides |
11/30/2000 | WO2000046378A3 Method of improving the primary energy metabolism of mammalian cell lines |
11/30/2000 | WO2000046358A3 Arabidopsis thaliana derived frigida gene conferring late flowering |
11/30/2000 | WO2000046355A3 Telomerase reverse transcriptase transcriptional regulatory sequences |
11/30/2000 | WO2000044934A3 Method of identifying cytosine methylation patterns in genomic dna samples |
11/30/2000 | WO2000044900A3 Nucleic-acid binding proteins |
11/30/2000 | WO2000044772A3 Human serum albumin |
11/30/2000 | WO2000043790A3 Compositions and methods for the diagnosis and treatment of tumor |
11/30/2000 | WO2000043539A3 Immobilization of molecules on surfaces via polymer brushes |
11/30/2000 | WO2000043525A3 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
11/30/2000 | WO2000043520A3 Materials and methods for producing geminivirus resistant plants |
11/30/2000 | WO2000043014A3 Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
11/30/2000 | WO2000042217A3 Method for electrochemically detecting nucleic acid-oligomer hybridisation events |
11/30/2000 | WO2000042207A3 Soybean transformation method |